A Study to Evaluate Efficacy and Safety of TEZ/IVA in Subjects Aged 6 Through 11 Years With Cystic Fibrosis

NCT03559062 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: TEZ/IVA
DRUG: IVA
DRUG: Placebo
DRUG: Placebo

Sponsor

Vertex Pharmaceuticals Incorporated